ACM
PFE icon

Altrius Capital Management’s Pfizer PFE Stock Holding History

Altrius Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.22M Buy
216,580
+13,491
+7% +$353K 0.99% 62
2026
Q1 		$5.7M Buy
203,089
+6,115
+3% +$163K 1.13% 45
2025
Q4 		$4.9M Buy
196,974
+3,454
+2% +$87.1K 1.04% 60
2025
Q3 		$4.93M Buy
193,520
+6,490
+3% +$160K 1.12% 51
2025
Q2 		$4.53M Buy
187,030
+12,380
+7% +$289K 1.06% 50
2025
Q1 		$4.43M Buy
174,650
+5,016
+3% +$131K 1.08% 54
2024
Q4 		$4.5M Buy
169,634
+17,050
+11% +$462K 1.21% 44
2024
Q3 		$4.42M Buy
152,584
+4,350
+3% +$127K 1.11% 58
2024
Q2 		$4.15M Buy
148,234
+2,330
+2% +$64.1K 1.09% 55
2024
Q1 		$4.05M Buy
145,904
+13,888
+11% +$385K 1.02% 58
2023
Q4 		$3.8M Buy
132,016
+34,783
+36% +$1.05M 1.06% 50
2023
Q3 		$3.23M Buy
97,233
+13,169
+16% +$466K 0.96% 59
2023
Q2 		$3.08M Buy
84,064
+1,842
+2% +$71.7K 0.91% 63
2023
Q1 		$3.35M Buy
82,222
+15,411
+23% +$666K 1.03% 49
2022
Q4 		$3.42M Sell
66,811
-2,036
-3% -$97.6K 1.07% 44
2022
Q3 		$3.01M Sell
68,847
-32,923
-32% -$1.6M 1.15% 34
2022
Q2 		$5.33M Buy
+101,770
New +$5.19M 1.73% 5

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Altrius Capital Management's PFE Position: Q2 2026 in Review

Altrius Capital Management increased its Pfizer (PFE) stake by 6.6% in Q2 2026, buying an estimated $353K and bringing the position to 216,580 shares worth $5.22M. The position accounts for 0.99% of the portfolio, ranked #62.

Altrius Capital Management first reported a position in PFE in Q2 2022 and has held it in 17 quarters since. The position peaked at $5.7M in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Altrius Capital Management held 216,580 shares of Pfizer worth $5.22M as of Q2 2026.
  • Altrius Capital Management bought 13,491 Pfizer shares in Q2 2026, an estimated $353K.
  • Pfizer made up 0.99% of Altrius Capital Management's portfolio in Q2 2026, its #62 holding.
  • Altrius Capital Management first reported a position in Pfizer in Q2 2022 and has held it in 17 quarters since.
  • Altrius Capital Management's Pfizer position peaked at $5.7M in Q1 2026.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Altrius Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.